References
- Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States 2001–02. Vital Health Stat. 2006;13:1–66.
- Irwin RS, Baumann MH, Boulet L-P, Braman SS. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):1S–23S.
- French CT, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med. 1998;158(15):1657–1661.
- Irwin RS, Curley FJ, French CL. Chronic cough: the spectrum and frequency of causes, key components of diagnostic evaluation, and outcomes of specific therapy. Am Rev Respir Dis. 1990;141(3):640–647.
- Ruhl CE, Everhart JE. Risk factors for inguinal hernia among adults in the US population. Am J Epidemiol. 2007;165(10):1154–1161.
- Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J. 2005;24(5 Suppl):S44–S47.
- Dicpinigaitis PV, Tso R, Banauch G. Prevalence of depressive symptoms among patients with chronic cough. Chest. 2006;130(6):1839–1843.
- McGarvey LPA, Carton C, Gamble LA, Heaney LG, et al. Prevalence of psychomorbidity among patients with chronic cough. Cough. 2006;2:4.
- Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis. 1981;123(4):413–417.
- Hoffstein V. Persistent cough in nonsmokers. Can Respir J. 1994;1(1):40–47.
- Gibson PG, Vertigan AE. Gabapentin in chronic cough. Pulm Pharmacol Ther. 2015;35:145–148.
- Field SK, Conley DP, Thawer AM, et al. Assessment and management of patients with chronic cough by Certified Respiratory Educators: a randomized controlled trial. Can Respir J. 2009;16(2):49–54.
- Field SK, Conley DP, Thawer AM, Leigh R, Cowie RL. Effect of the management of patients with chronic cough by pulmonologists and certified respiratory educators on quality of life: a randomized trial. Chest. 2009;136(4):1021–1028.
- Gibson PG, Vertigan AE. Speech pathology for chronic cough: a new approach. Pulm Pharmacol Ther. 2009;22(2):159–162.
- Morrison M, Rammage L, Emami AJ. The irritable larynx syndrome. J Voice. 1999;13(3):447–455.
- Gibson PG, Vertigan AE. Management of chronic refractory cough. BMJ. 2015;351:h5590.
- Taramarcaz P, Grissell TV, Borgas T, Gibson PG. Transient postviral vocal cord dysfunction. J Allergy Clin Immunol. 2004;114(6):1471–1472.
- Jeyakumar A, Brickman TM, Haben M. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope. 2006;116(12):2108–2112.
- Amin MR, Koufman JA. Vagal neuropathy after upper respiratory infection: a viral etiology? Am J Otolaryngol. 2001;22(4):251–256.
- Abdullah H, Heaney LG, Cosby SL, McGarvey LPA. Rhinovirus upregulates transient receptor potential channels in a human neuronal line: implications for respiratory virus-induced cough reflex sensitivity. Thorax 2014;69(1):46–54.
- Zaccone EJ, Lieu TMarie, Muroi Y, et al. Parainfluenza 3-induced cough hypersensitivity in the guinea pig airways. PLoS One. 2016;11(5):e0155526.
- Lee L-Y, Ni D, Hayes D, Lin R-L. TRPV1 as a cough sensor and its temperature-sensitive properties. Pulm Pharmacol Ther. 2011;24(3):280–285.
- Grace MS, Belvisi MG. TRPA1 receptors in cough. Pulm Pharmacol Ther. 2011;24(3):286–288.
- Khalid S, Murdoch R, Newlands A, Smart K, Kelsall A, et al. Transient receptor potential randomized controlled trial. J Allergy Clin Immunol. 2014;134(1):56–62.
- O'Connell F, Springall DR, Moradoghli-Haftvani A, et al. Abnormal intraepithelial airway nerves in persistent unexplained cough? Am J Respir Crit Care Med. 1995;152(6):2068–2075.
- Vertigan AE, Gibson PG. Chronic refractory cough as a sensory neuropathy: evidence from a reinterpretation of cough triggers. J Voice. 2011;25(5):596–601.
- Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomized, double-blind, placebo-controlled trial. Lancet.2012;380(9853):1583–1589.
- Niimi A, Chung KF. Evidence for neuropathic processes in chronic cough. Pulm Pharmacol Ther. 2015;35:100–104.
- Ryan NM, Vertigan AE, Bone S, Gibson PG. Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough. 2010;6:5.
- Gibson P, Wang G, McGarvey L, et al. Treatment of unexplained chronic cough: Chest guideline and expert panel report. Chest. 2016;149(1):27–44.
- Morice AH, Menon MS, Mulrennan SA, Everett CF, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med. 2007;175(4):312–315.
- Xu X-H, Yang Z-M, Chen Q, Yu L, et al. Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough. WJG. 2013;19(27):4386–4392.
- Keller JA, McGovern AE, Mazzone SB. Translating cough mechanisms into better cough suppressants. Chest. 2017;152(4):833–841.
- Lee B, Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol. 2005;114(4):253–257.
- Giliberto JP, Dibildox D, Merati A. Unilateral laryngoscopic findings associated with response to gabapentin in patients with chronic cough. JAMA Otolaryngol Head Neck Surg. 2017;143(11):1081–1085.
- Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest 2016;149(3):639–648.
- Kahrilas PJ, Altman KW, Chang AB, Field SK, et al. Chronic cough due to gastroesophageal reflux in adults. Chest guideline and expert report. Chest. 2016;150(6):1341–1360.
- Belvisi MG, Birrell MA, Wortley MA, Maher SA, et al. XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough. Am J Respir Crit Care Med. 2017;196(10):1255–1263.
- Smith JA, McGarvey LPA, Badri H, Satia I, et al. Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough. Int J Clin Pharmacol Ther. 2017;55(9):712–719.
- Abdulqawi R, Dockry R, Holt K, Layton G, et al. P2X2 receptor antagonist (AF-219) in refractory chronic cough: a randomized, double-blind. Lancet. 2015;385(9974):1198–1205.
- Smith JA, Kitt M, Butera P, Ford A. The effects of P2X3 antagonism (AF-219) on experimentally evoked cough in healthy volunteers and chronic cough patients. Thorax. 2016;71(Suppl 3):A17. (abstract)
- Harle ASM, Smith JA, Molassiotis A, et al. A placebo-controlled trial of aprepitant for cough in lung cancer. JCO. 2015;33(29_suppl):2. (abstract).
- Everett CF, Kastelik JA, Thompson RH, Morice AH. Chronic persistent cough in the community: a questionnaire survey. Cough 2007;3(1):5. doi:10.1186/1745-9974-3-5